Cardiovascular disease associated with radiotherapy: Activation of nuclear factor kappa-B

Journal of Internal Medicine

Volumn 269, Issue 5, 2011, Pages 469-477

  Halle, M ^a   Hall, P ^b   Tornvall, P ^c  

^a Section of Reconstructive Plastic Surgery   (Sweden)

^b Department of Medical Epidemiology and Biostatistics ^*  (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cardiovascular disease; Endothelial dysfunction; Inflammation; Nuclear factor kappa B; Radiation injuries; Radiotherapy adverse effects

Indexed keywords

BEVACIZUMAB; CAMPTOTHECIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; VASCULOTROPIN INHIBITOR;

ARTICLE; ATHEROSCLEROSIS; BONE MARROW TRANSPLANTATION; BRAIN TUMOR; BREAST CANCER; BYSTANDER EFFECT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM TUMOR; DIABETES MELLITUS; DISEASE ASSOCIATION; DNA DAMAGE; HEAD AND NECK CANCER; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HODGKIN DISEASE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MORTALITY; NEOPLASM; NONHUMAN; PELVIS CANCER; PERICARDIAL DISEASE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RETINOPATHY; SMOKING; STEM CELL TRANSPLANTATION; STROKE; TISSUE INJURY; UNSPECIFIED SIDE EFFECT; VALVULAR HEART DISEASE; VASCULAR DISEASE;

CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; HUMANS; NF-KAPPA B; RADIATION ONCOLOGY; RADIOTHERAPY; REACTIVE OXYGEN SPECIES; RISK FACTORS;

EID: 79954974254     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2011.02353.x     Document Type: Article

References (91)

1. Rowland JH, Hewitt M, Ganz PA. Cancer survivorship: a new challenge in delivering quality cancer care. J Clin Oncol 2006; 24: 5101-4.
2. Silverberg GD, Britt RH, Goffinet DR. Radiation-induced carotid artery disease. Cancer 1978; 41: 130-7.
3. Darby S, McGale P, Peto R, Granath F, Hall P, Ekbom A. Mortality from cardiovascular disease more than 10years after radiotherapy for breast cancer: nationwide cohort study of 90000 Swedish women. BMJ 2003; 326: 256-7.
4. Dorresteijn LD, Kappelle AC, Scholz NM et al. Increased carotid wall thickening after radiotherapy on the neck. Eur J Cancer 2005; 41: 1026-30.
5. Ullrich NJ, Robertson R, Kinnamon DD et al. Moyamoya following cranial irradiation for primary brain tumors in children. Neurology 2007; 68: 932-8.
6. Altena R, Perik PJ, van Veldhuisen DJ, de Vries EG, Gietema JA. Cardiovascular toxicity caused by cancer treatment: strategies for early detection. Lancet Oncol 2009; 10: 391-9.
7. Basavaraju SR, Easterly CE. Pathophysiological effects of radiation on atherosclerosis development and progression, and the incidence of cardiovascular complications. Med Phys 2002; 29: 2391-403.
8. Baerlocher MO, Rajan DK, Ing DJ, Rubin BB. Primary stenting of bilateral radiation-induced external iliac stenoses. J Vasc Surg 2004; 40: 1028-31.
9. Stewart FA, Heeneman S, Te Poele J et al. Ionizing radiation accelerates the development of atherosclerotic lesions in ApoE-/- mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage. Am J Pathol 2006; 168: 649-58.
10. Sugihara T, Hattori Y, Yamamoto Y et al. Preferential impairment of nitric oxide-mediated endothelium-dependent relaxation in human cervical arteries after irradiation. Circulation 1999; 100: 635-41.
11. Beckman JA, Thakore A, Kalinowski BH, Harris JR, Creager MA. Radiation therapy impairs endothelium-dependent vasodilation in humans. J Am Coll Cardiol 2001; 37: 761-5.
12. Napoli C, Ignarro LJ. Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases. Arch Pharm Res 2009; 32: 1103-8.
13. Russell NS, Hoving S, Heeneman S et al. Novel insights into pathological changes in muscular arteries of radiotherapy patients. Radiother Oncol 2009; 92: 477-83.
14. Perry A, Schmidt RE. Cancer therapy-associated CNS neuropathology: an update and review of the literature. Acta Neuropathol 2006; 111: 197-212.
15. Omura M, Aida N, Sekido K, Kakehi M, Matsubara S. Large intracranial vessel occlusive vasculopathy after radiation therapy in children: clinical features and usefulness of magnetic resonance imaging. Int J Radiat Oncol Biol Phys 1997; 38: 241-9.
16. Ferrero V, Ribichini F, Piessens M et al. Intracoronary beta-irradiation for the treatment of de novo lesions: 5-year clinical follow-up of the BetAce randomized trial. Am Heart J 2007; 153: 398-402.
17. Waksman R, Bhargava B, Mintz GS et al. Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis. J Am Coll Cardiol 2000; 36: 65-8.
18. Mulrooney DA, Yeazel MW, Kawashima T et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ 2009; 339: b4606.
19. Tukenova M, Guibout C, Oberlin O et al. Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. J Clin Oncol 2010; 28: 1308-15.
20. Gaya AM, Ashford RF. Cardiac complications of radiation therapy. Clin Oncol (R Coll Radiol) 2005; 17: 153-9.
21. Clarke M, Collins R, Darby S et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366: 2087-106.
22. Hooning MJ, Botma A, Aleman BM et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst 2007; 99: 365-75.
23. Bowers DC, Mulne AF, Reisch JS et al. Nonperioperative strokes in children with central nervous system tumors. Cancer 2002; 94: 1094-101.
24. Gurney JG, Kadan-Lottick NS, Packer RJ et al. Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer 2003; 97: 663-73.
25. Bowers DC, McNeil DE, Liu Y et al. Stroke as a late treatment effect of Hodgkin's Disease: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2005; 23: 6508-15.
26. Smith GL, Smith BD, Buchholz TA et al. Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy. J Clin Oncol 2008; 26: 5119-25.
27. De Bruin ML, Dorresteijn LD, van't Veer MB et al. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. J Natl Cancer Inst 2009; 101: 928-37.
28. Dorresteijn LD, Kappelle AC, Boogerd W et al. Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60years. J Clin Oncol 2002; 20: 282-8.
29. Bitzer M, Topka H. Progressive cerebral occlusive disease after radiation therapy. Stroke 1995; 26: 131-6.
30. Brant-Zawadzki M, Anderson M, DeArmond SJ, Conley FK, Jahnke RW. Radiation-induced large intracranial vessel occlusive vasculopathy. AJR Am J Roentgenol 1980; 134: 51-5.
31. Farrugia M, Gowda KM, Cheatle TR, Ashok TP. Radiotherapy-related axillary artery occlusive disease: percutaneous transluminal angioplasty and stenting. Two case reports and review of the literature. Cardiovasc Intervent Radiol 2006; 29: 1144-7.
32. Zhou W, Bush RL, Lin PH, Lumsden AB. Radiation-associated venous stenosis: endovascular treatment options. J Vasc Surg 2004; 40: 179-82.
33. Parsons JT, Bova FJ, Mendenhall WM, Million RR, Fitzgerald CR. Response of the normal eye to high dose radiotherapy. Oncology (Williston Park) 1996; 10: 837-47; discussion 47-8, 51-2.
34. Archer DB, Amoaku WM, Gardiner TA. Radiation retinopathy - clinical, histopathological, ultrastructural and experimental correlations. Eye (Lond) 1991; 5(Pt 2): 239-51.
35. Hatoum OA, Otterson MF, Kopelman D et al. Radiation induces endothelial dysfunction in murine intestinal arterioles via enhanced production of reactive oxygen species. Arterioscler Thromb Vasc Biol 2006; 26: 287-94.
36. Schultze-Mosgau S, Rodel F, Radespiel-Troger M, Worl J, Grabenbauer GG, Neukam FW. Vascularization of the area between free grafts and irradiated graft beds in the neck in rats. Br J Oral Maxillofac Surg 2002; 40: 37-44.
37. Schultze-Mosgau S, Grabenbauer GG, Radespiel-Troger M et al. Vascularization in the transition area between free grafted soft tissues and pre-irradiated graft bed tissues following preoperative radiotherapy in the head and neck region. Head Neck 2002; 24: 42-51.
38. Halle M, Bodin I, Tornvall P, Wickman M, Farnebo F, Arnander C. Timing of radiotherapy in head and neck free flap reconstruction - a study of postoperative complications. J Plast Reconstr Aesthet Surg 2009; 62: 889-95.
39. Halle M, Ekstrom M, Farnebo F, Tornvall P. Endothelial activation with prothrombotic response in irradiated microvascular recipient veins. J Plast Reconstr Aesthet Surg 2010; 63: 1910-6.
40. Robbins ME, Zhao W. Chronic oxidative stress and radiation-induced late normal tissue injury: a review. Int J Radiat Biol 2004; 80: 251-9.
41. Stone HB, Coleman CN, Anscher MS, McBride WH. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol 2003; 4: 529-36.
42. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006; 6: 508-19.
43. Gaugler MH, Squiban C, Claraz M et al. Characterization of the response of human bone marrow endothelial cells to in vitro irradiation. Br J Haematol 1998; 103: 980-9.
44. Gaugler MH, Squiban C, Mouthon MA, Gourmelon P, van der Meeren A. Irradiation enhances the support of haemopoietic cell transmigration, proliferation and differentiation by endothelial cells. Br J Haematol 2001; 113: 940-50.
45. Fischer-Dzoga K, Dimitrievich GS, Griem ML. Radiosensitivity of vascular tissue. II. Differential radiosensitivity of aortic cells in vitro. Radiat Res 1984; 99: 536-46.
46. van Kleef EM, te Poele JA, Oussoren YG et al. Increased expression of glomerular von Willebrand factor after irradiation of the mouse kidney. Radiat Res 1998; 150: 528-34.
47. Wang J, Zheng H, Ou X, Fink LM, Hauer-Jensen M. Deficiency of microvascular thrombomodulin and up-regulation of protease-activated receptor-1 in irradiated rat intestine: possible link between endothelial dysfunction and chronic radiation fibrosis. Am J Pathol 2002; 160: 2063-72.
48. Paris F, Fuks Z, Kang A et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 2001; 293: 293-7.
49. Molla M, Gironella M, Miquel R et al. Relative roles of ICAM-1 and VCAM-1 in the pathogenesis of experimental radiation-induced intestinal inflammation. Int J Radiat Oncol Biol Phys 2003; 57: 264-73.
50. Panes J, Molla M, Casadevall M et al. Tepoxalin inhibits inflammation and microvascular dysfunction induced by abdominal irradiation in rats. Aliment Pharmacol Ther 2000; 14: 841-50.
51. Qi F, Sugihara T, Hattori Y, Yamamoto Y, Kanno M, Abe K. Functional and morphological damage of endothelium in rabbit ear artery following irradiation with cobalt60. Br J Pharmacol 1998; 123: 653-60.
52. Victor VM, Rocha M, Sola E, Banuls C, Garcia-Malpartida K, Hernandez-Mijares A. Oxidative stress, endothelial dysfunction and atherosclerosis. Curr Pharm Des 2009; 15: 2988-3002.
53. Pepine CJ. The impact of nitric oxide in cardiovascular medicine: untapped potential utility. Am J Med 2009; 122(Suppl 5): S10-5.
54. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003; 23: 168-75.
55. Panes J, Anderson DC, Miyasaka M, Granger DN. Role of leukocyte-endothelial cell adhesion in radiation-induced microvascular dysfunction in rats. Gastroenterology 1995; 108: 1761-9.
56. Hallahan D, Clark ET, Kuchibhotla J, Gewertz BL, Collins T. E-selectin gene induction by ionizing radiation is independent of cytokine induction. Biochem Biophys Res Commun 1995; 217: 784-95.
57. Gaugler MH, Squiban C, van der Meeren A, Bertho JM, Vandamme M, Mouthon MA. Late and persistent up-regulation of intercellular adhesion molecule-1 (ICAM-1) expression by ionizing radiation in human endothelial cells in vitro. Int J Radiat Biol 1997; 72: 201-9.
58. Vereycken-Holler V, Aigueperse J, Gaugler MH. Radiation effects on circulating and endothelial cell interactions studied by quantitative real-time videomicroscopy. Int J Radiat Biol 2002; 78: 923-30.
59. Quarmby S, Kumar P, Kumar S. Radiation-induced normal tissue injury: role of adhesion molecules in leukocyte-endothelial cell interactions. Int J Cancer 1999; 82: 385-95.
60. Salame MY, Verheye S, Mulkey SP et al. The effect of endovascular irradiation on platelet recruitment at sites of balloon angioplasty in pig coronary arteries. Circulation 2000; 101: 1087-90.
61. Deiner C, Shagdarsuren E, Schwimmbeck PL et al. Nf-kappab and AP-1 activation is associated with late lumen loss after porcine coronary angioplasty and antiproliferative beta-irradiation. Cardiovasc Res 2007; 75: 195-204.
62. Halle M, Gabrielsen A, Paulsson-Berne G et al. Sustained inflammation due to nuclear factor-kappa B activation in irradiated human arteries. J Am Coll Cardiol 2010; 55: 1227-36.
63. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J 1995; 9: 899-909.
64. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-9.
65. Iademarco MF, McQuillan JJ, Dean DC. Vascular cell adhesion molecule 1: contrasting transcriptional control mechanisms in muscle and endothelium. Proc Natl Acad Sci U S A 1993; 90: 3943-7.
66. Caldenhoven E, Coffer P, Yuan J et al. Stimulation of the human intercellular adhesion molecule-1 promoter by interleukin-6 and interferon-gamma involves binding of distinct factors to a palindromic response element. J Biol Chem 1994; 269: 21146-54.
67. Read MA, Whitley MZ, Gupta S et al. Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor-kappaB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways. J Biol Chem 1997; 272: 2753-61.
68. Xanthoulea S, Curfs DM, Hofker MH, de Winther MP. Nuclear factor kappa B signaling in macrophage function and atherogenesis. Curr Opin Lipidol 2005; 16: 536-42.
69. Collins T, Cybulsky MI. NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest 2001; 107: 255-64.
70. Trivedi CM, Patel RC, Patel CV. Differential regulation of HOXA9 expression by nuclear factor kappa B (NF-kappaB) and HOXA9. Gene 2008; 408: 187-95.
71. Landry DB, Couper LL, Bryant SR, Lindner V. Activation of the NF-kappa B and I kappa B system in smooth muscle cells after rat arterial injury. Induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1. Am J Pathol 1997; 151: 1085-95.
72. Raines EW, Garton KJ, Ferri N. Beyond the endothelium: NF-kappaB regulation of smooth muscle function. Circ Res 2004; 94: 706-8.
73. Jovinge S, Hultgardh-Nilsson A, Regnstrom J, Nilsson J. Tumor necrosis factor-alpha activates smooth muscle cell migration in culture and is expressed in the balloon-injured rat aorta. Arterioscler Thromb Vasc Biol 1997; 17: 490-7.
74. Morgan WF, Sowa MB. Non-targeted bystander effects induced by ionizing radiation. Mutat Res 2007; 616: 159-64.
75. Criswell T, Leskov K, Miyamoto S, Luo G, Boothman DA. Transcription factors activated in mammalian cells after clinically relevant doses of ionizing radiation. Oncogene 2003; 22: 5813-27.
76. Huang TT, Wuerzberger-Davis SM, Seufzer BJ et al. NF-kappaB activation by camptothecin. A linkage between nuclear DNA damage and cytoplasmic signaling events. J Biol Chem 2000; 275: 9501-9.
77. Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature 2000; 408: 433-9.
78. Habraken Y, Piette J. NF-kappaB activation by double-strand breaks. Biochem Pharmacol 2006; 72: 1132-41.
79. Schultz-Hector S, Trott KR. Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data? Int J Radiat Oncol Biol Phys 2007; 67: 10-8.
80. Taylor CW, Nisbet A, McGale P et al. Cardiac doses from Swedish breast cancer radiotherapy since the 1950s. Radiother Oncol 2009; 90: 127-35.
81. Aleman BM, de Bruin ML, Dorresteijn LD et al. Re: late effects from radiation therapy: the hits just keep on coming. J Natl Cancer Inst 2010; 102: 576-7; author reply 7-8.
82. Finger PT, Chin K. Anti-vascular endothelial growth factor bevacizumab (avastin) for radiation retinopathy. Arch Ophthalmol 2007; 125: 751-6.
83. Angelo LS, Kurzrock R. Vascular endothelial growth factor and its relationship to inflammatory mediators. Clin Cancer Res 2007; 13: 2825-30.
84. Huang S, Robinson JB, Deguzman A, Bucana CD, Fidler IJ. Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. Cancer Res 2000; 60: 5334-9.
85. Kimba Y, Abe T, Wu JL et al. Mutant IkappaBalpha suppresses hypoxia-induced VEGF expression through downregulation of HIF-1alpha and COX-2 in human glioma cells. Oncol Res 2005; 15: 139-49.
86. Kruithof EK. Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins. Thromb Haemost 2008; 100: 969-75.
87. Jain MK, Ridker PM. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov 2005; 4: 977-87.
88. Gaugler MH, Vereycken-Holler V, Squiban C, Vandamme M, Vozenin-Brotons MC, Benderitter M. Pravastatin limits endothelial activation after irradiation and decreases the resulting inflammatory and thrombotic responses. Radiat Res 2005; 163: 479-87.
89. Holler V, Buard V, Gaugler MH et al. Pravastatin limits radiation-induced vascular dysfunction in the skin. J Invest Dermatol 2009; 129: 1280-91.
90. Stewart FA, Dorr W. Milestones in normal tissue radiation biology over the past 50years: from clonogenic cell survival to cytokine networks and back to stem cell recovery. Int J Radiat Biol 2009; 85: 574-86.
91. Subramaniyam V, Waller EK, Murrow JR et al. Bone marrow mobilization with granulocyte macrophage colony-stimulating factor improves endothelial dysfunction and exercise capacity in patients with peripheral arterial disease. Am Heart J 2009; 158: 53-60.